Stay updated on Vaccine Therapy with Pembrolizumab in Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Vaccine Therapy with Pembrolizumab in Prostate Cancer Clinical Trial page.

Latest updates to the Vaccine Therapy with Pembrolizumab in Prostate Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.0%
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedThe webpage has been updated to include new identifiers and collaborators related to a clinical trial for hormone-resistant metastatic prostate cancer, while significant details about the trial's objectives and treatment protocols have been removed.SummaryDifference48%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.8%
- Check88 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference0.8%
Stay in the know with updates to Vaccine Therapy with Pembrolizumab in Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vaccine Therapy with Pembrolizumab in Prostate Cancer Clinical Trial page.